2019
DOI: 10.3389/fimmu.2019.01584
|View full text |Cite
|
Sign up to set email alerts
|

Head Start Immunity: Characterizing the Early Protection of C Strain Vaccine Against Subsequent Classical Swine Fever Virus Infection

Abstract: Classical Swine Fever Virus (CSFV) is an ongoing threat to the pig industry due to the high transmission and mortality rates associated with infection. Live attenuated vaccines such as the CSFV C strain vaccine are capable of protecting against infection within 5 days of vaccination, but the molecular mechanisms through which this early protection is mediated have yet to be established. In this study, we compared the response of pigs vaccinated with the C strain to non-vaccinated pigs both challenged with a pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 57 publications
1
8
0
Order By: Relevance
“…Therefore, we speculated that ISG15 might be induced by CSFV in an IFN-independent manner in PAMs, which will be further verified in future studies. Similar results were obtained in research of Vaccine-Cstrain; the ISG15 pathway was activated in response to Vaccine C-strain and ISG15 played a role in the rapid and early protection conferred by Vaccine C-strain [27]. In further research, we will test ISG15 effects on more CSFV genotypes to perfect the mechanisms of ISG15.…”
Section: Discussionsupporting
confidence: 76%
“…Therefore, we speculated that ISG15 might be induced by CSFV in an IFN-independent manner in PAMs, which will be further verified in future studies. Similar results were obtained in research of Vaccine-Cstrain; the ISG15 pathway was activated in response to Vaccine C-strain and ISG15 played a role in the rapid and early protection conferred by Vaccine C-strain [27]. In further research, we will test ISG15 effects on more CSFV genotypes to perfect the mechanisms of ISG15.…”
Section: Discussionsupporting
confidence: 76%
“…[36][37][38][39] Preliminary in vitro data suggest potential in the application of both rhIFNα and Zelnate in the treatment of clinical EEHV infections and give a plausible mode of action to justify their use. 40 41 Although EEHVs are likely to possess IFN-evasion strategies as described in other herpesviruses, [42][43][44] the concept of head-start immunity has been proposed, 45 whereby these viral defences can be pre-empted and, with sufficient and timely activation of the IFN system, can overcome infection, as highlighted by IFN-based treatment strategies for chronic hepatitis B virus. 46 EEHV-HD is thought to be the result of primary infection in immunologically naive animals, following the decline of maternally derived antibodies.…”
Section: Discussionmentioning
confidence: 99%
“…The emergence of a local CD8 + T cell response in the tonsil following C-strain vaccination is supported by a recent transcriptional analysis of tonsil tissue. Here, tissue from C-strain vaccinated pigs demonstrated an upregulation of eomes, a transcription factor, known to play a key role in the differentiation of effector CD8 T cells [48].…”
Section: Discussionmentioning
confidence: 84%